Your session is about to expire
← Back to Search
Behavioral Activation and Exposure Therapy for Anxiety and Depression in Youth
N/A
Recruiting
Led By Brian C Chu, Ph.D.
Research Sponsored by Rutgers University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Major Depression Disorder (MDD)
Separation Anxiety Disorder (SEP)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from pre-treatment to post-treatment (baseline to 14-weeks)
Awards & highlights
No Placebo-Only Group
Summary
This trial will compare the effectiveness of different psychological treatments for anxiety and depression in youth, as well as how well each treatment works to change specific aspects related to the disorders.
Who is the study for?
This trial is for young people aged 9-17 with anxiety or depression disorders, including Generalized Anxiety Disorder, Separation Anxiety Disorder, Social Phobia, Specific Phobia, Panic Disorder, Agoraphobia, Major Depression Disorder and other depressive conditions.
What is being tested?
The study compares Individual Behavioral Activation Therapy (IBAT) to two specific psychological programs (Coping Cat for anxiety and PASCET for depression), as well as a waitlist control group to see which is more effective in treating youth with these mental health issues.
What are the potential side effects?
Since the interventions are psychological therapies rather than medications, traditional side effects are not expected. However participants may experience emotional discomfort discussing personal issues during therapy sessions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with Major Depression Disorder.
Select...
I have been diagnosed with separation anxiety disorder.
Select...
I have been diagnosed with Social Anxiety Disorder.
Select...
I have been diagnosed with Persistent Depressive Disorder.
Select...
I have been diagnosed with Generalized Anxiety Disorder.
Select...
I have been diagnosed with Panic Disorder.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from pre-treatment to post-treatment (baseline to 14-weeks)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from pre-treatment to post-treatment (baseline to 14-weeks)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Clinical Global Impression Severity (CGIS) Scale: Independent Evaluator
Secondary study objectives
Change in Behavioral Activation
Child Automatic Thoughts Scale-Negative/Positive
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Principal Depressive DisorderExperimental Treatment3 Interventions
Youth with a principal unipolar depressive disorder
Group II: Principal Anxiety DisorderExperimental Treatment3 Interventions
Youth with a principal anxiety disorder
Find a Location
Who is running the clinical trial?
Rutgers UniversityLead Sponsor
121 Previous Clinical Trials
2,809,154 Total Patients Enrolled
10 Trials studying Depression
7,213 Patients Enrolled for Depression
Brian C Chu, Ph.D.Principal InvestigatorRutgers University (Youth Anxiety and Depression Clinic)
2 Previous Clinical Trials
1,295 Total Patients Enrolled
2 Trials studying Depression
1,295 Patients Enrolled for Depression